live attenuated SARS CoV 2 vaccine
live attenuated SARS CoV 2 vaccine: will be used in the treatment of COVID-19 Virus.
For this vaccine, Vaccine manufacturer Indian Immunologicals (IIL) has shaken their hand with Australia’s Griffith University. IIL will make researchers and will develop a vaccine with the help of Australian Griffith University.
And both of signed agreements for developing live-attenuated SARS-CoV-2 vaccine.
- As per agreements, Scientists from both nations India and Australia will make ‘live attenuated SARS CoV 2 vaccine‘ together. they will use the latest codon deoptimization technology for the vaccine.
- It can be expected that The vaccine will give long-lasting protection with a single-dose administration.
- After completing research, the vaccine strain will be sent to ILL that is to work with the Central Drugs Standard Control Organisation (CDSCO), to take clinical trials. IIL is expecting to use its Vero cell platform tech for massive production of the vaccines.
Q.1 What is use of ive attenuated SARS CoV 2 vaccine?
ive attenuated SARS CoV 2 vaccine will be used to treat patients of COVID-19 Virus.
Q.2 where Australian Griffith University is located ?
Australian Griffith University is located in South East Queensland, Australia.